Mulberry leaf polyphenol extracts reduced hepatic lipid accumulation involving regulation of adenosine monophosphate activated protein kinase and lipogenic enzymes

Journal of Functional Foods

Volumn 5, Issue 4, 2013, Pages 1620-1632

  Wu, Cheng Hsun ^a,b,d   Chen, Shu Chun ^a   Ou, Ting Tsz ^a   Chyau, Charng Cherng ^e   Chang, Yun Ching ^a,c   Wang, Chau Jong ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Acetyl CoA carboxylase; AMP actived protein kinase; Fatty acid synthetase; HMG CoA reductase; Mulberry leaf polyphenol extracts; Non alcoholic fatty liver disease

Indexed keywords

MORUS (ANGIOSPERM);

EID: 84888440253     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.07.004     Document Type: Article

References (44)

1. Adams L.A., Angulo P., Lindor K.D. Nonalcoholic fatty liver disease. Canadian Medical Association Journal 2005, 172(7):899-905.
2. Arabshahi-Delouee S., Urooj A. Antioxidant properties of various solvent extracts of mulberry (Morus indica L.) leaves. Food Chemistry 2007, 102:1233-1240.
3. Assy N., Kaita K., Mymin D., Levy C., Rosser B., Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Digestive Diseases and Sciences 2000, 45(10):1929-1934.
4. Auger C., Teissedre P.L., Gerain P., Lequeux N., Bornet A., Serisier S., Besancon P., Caporiccio B., Cristol J.P., Rouanet J.M. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. Journal of Agricultural and Food Chemistry 2005, 53(6):2015-2021.
5. Brooks S.C., Brooks J.S., Lee W.H., Lee M.G., Kim S.G. Therapeutic potential of dithiolethiones for hepatic diseases. Pharmacology & Therapeutics 2009, 124(1):31-43.
6. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89(3):331-340.
7. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends in Biochemical Sciences 2004, 29(1):18-24.
8. Chan K.C., Ho H.H., Peng C.H., Lan K.P., Lin M.C., Chen H.M., Wang C.J. Polyphenol-rich extract from mulberry leaf inhibits vascular smooth muscle cell proliferation involving upregulation of p53 and inhibition of cyclin-dependent kinase. Journal of Agricultural and Food Chemistry 2010, 58(4):2536-2542.
9. Chang Y.Y., Yang J., Chiu C.H., Lin Y.L., Chen J.W., Chen Y.C. Antioxidative and anti-inflammatory effects of polyphenol-rich litchi (Litchi chinensis Sonn.)-flower-water-extract on livers of high-fat-diet fed hamsters. Journal of Functional Foods 2013, 5:44-52.
10. Chou M.C., Chang R., Hung Y.H., Chen Y.C., Chiu C.H. Antrodia camphorata ameliorates high-fat-diet induced hepatic steatosis via improving lipid metabolism and antioxidative status. Journal of Functional Foods 2013, 5:1315-1317.
11. Duval C., Muller M., Kersten S. PPARalpha and dyslipidemia. Biochimica et Biophysica Acta 2007, 1771(8):961-971.
12. Edwards P.A., Tabor D., Kast H.R., Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochimica et Biophysica Acta 2000, 1529(1-3):103-113.
13. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nature Medicine 2004, 10(4):355-361.
14. Hardie D.G., Hawley S.A., Scott J.W. AMP-activated protein kinase-development of the energy sensor concept. The Journal of Physiology 2006, 574(Pt 1):7-15.
15. Hsu C.L., Yen G.C. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. British Journal of Nutrition 2007, 98:727-735.
16. Hwang J.T., Park I.J., Shin J.I., Lee Y.K., Lee S.K., Baik H.W., Ha J., Park O.J. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochemical and Biophysical Research Communications 2005, 338(2):694-699.
17. Katsube T., Imawaka N., Kawano Y., Yamazaki Y., Shiwaku K., Yamane Y. Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chemistry 2006, 97:25-31.
18. Kemp B.E., Stapleton D., Campbell D.J., Chen Z.P., Murthy S., Walter M., Gupta A., Adams J.J., Katsis F., van Denderen B., Jennings I.G., Iseli T., Michell B.J., Witters L.A. AMP-activated protein kinase, super metabolic regulator. Biochemical Society Transactions 2003, 31(Pt 1):162-168.
19. Kim S.Y., Gao J.J., Lee W.C., Ryu K.S., Lee K.R., Kim Y.C. Antioxidative flavonoids from the leaves of Morus alba. Archives of Pharmacal Research 1999, 22(1):81-85.
20. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404(6778):635-643.
21. Lakenbrink C., Lapczynski S., Maiwald B., Engelhardt U.H. Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. Journal of Agricultural and Food Chemistry 2000, 48(7):2848-2852.
22. Li B.H., Ma X.F., Wang Y., Tian W.X. Structure-activity relationship of polyphenols that inhibit fatty acid synthase. Journal of Biochemisty 2005, 138:679-685.
23. Liu W.H., Lin C.C., Wang Z.H., Mong M.C., Yin M.C. Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice. Journal of Agricultural and Food Chemistry 2010, 58:10247-10252.
24. Madan K., Bhardwaj P., Thareja S., Gupta S.D., Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). Journal of Clinical Gastroenterology 2006, 40(10):930-935.
25. Magana M.M., Osborne T.F. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. Journal of Biological Chemistry 1996, 271(51):32689-32694.
26. Muller H., Lindman A.S., Brantsaeter A.L., Pedersen J.I. The serum LDL/HDL cholesterol ratio is influenced more favorably by exchanging saturated with unsaturated fat than by reducing saturated fat in the diet of women. Journal of Nutrition 2003, 133(1):78-83.
27. Oliaro-Bosso S., Calcio Gaudino E., Mantegna S., Giraudo E., Meda C., Viola F., Cravotto G. Regulation of HMGCoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol. Lipids 2009, 44(10):907-916.
28. Qureshi K., Abrams G.A. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2007, 13(26):3540-3553.
29. Reddy J.K., Rao M.S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. American Journal of Physiology - Gastrointestinal and Liver Physiology 2006, 290(5):G852-858.
30. Ruderman N., Chisholm D., Pi-Sunyer X., Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998, 47(5):699-713.
31. Rusinol A.E., Yang L., Thewke D., Panini S.R., Kramer M.F., Sinensky M.S. Isolation of a somatic cell mutant resistant to the induction of apoptosis by oxidized low density lipoprotein. Journal of Biological Chemistry 2000, 275(10):7296-7303.
32. Sakakura Y., Shimano H., Sone H., Takahashi A., Inoue N., Toyoshima H., Suzuki S., Yamada N. Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochemical and Biophysical Research Communications 2001, 286(1):176-183.
33. Siddiqui M.J., Hafizoh S.N., Ismail Z., Sahib H.B., Helal M.H.S., Abdul-Majid A.M.S. Analysis of total proteins, polysaccharides and glycosaponins contents of orthosiphon stamineus benth. In spray and freeze dried methanol: water(1:1) extract and its contribution to cytotoxic and antiangiogenic activities. Pharmacognosy Research 2009, 1:320-326.
34. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Advances in Experimental Medicine and Biology 1995, 369:39-48.
35. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. The New England Journal of Medicine 1989, 320(14):915-924.
36. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006, 6(10):772-783.
37. Weissman C. Nutrition in the intensive care unit. Critical Care 1999, 3(5):R67-75.
38. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. The Journal of Clinical Investigation 2005, 115(5):1111-1119.
39. Weng M.S., Ho C.T., Ho Y.S., Lin J.K. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling. Toxicology and Applied Pharmacology 2007, 218(2):107-118.
40. Winder W.W., Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. American Journal of Physiology 1999, 277(1 Pt 1):E1-10.
41. Wu C.H., Lin M.C., Wang H.C., Yang M.Y., Jou M.J., Wang C.J. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. Journal of Food Science 2011, 76(2):T65-72.
42. Yang M.Y., Huang C.N., Chan K.C., Yang Y.S., Peng C.H., Wang C.J. Mulberry leaf polyphenols possess antiatherogenesis effect via inhibiting LDL oxidation and foam cell formation. Journal of Agricultural and Food Chemistry 2011, 59(5):1985-1995.
43. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation 2001, 108(8):1167-1174.
44. Ziaee A., Zamansoltani F., Nassiri-Asl M., Abbasi E. Effects of rutin on lipid profile in hypercholesterolaemic rats. Basic and Clinical Pharmacology and Toxicology 2009, 104(3):253-258.